期刊文献+

局部晚期宫颈腺癌与宫颈鳞癌对放化疗的反应对比 被引量:1

Comparative Analysis of the Chemoradiotherapy in the Local Advanced Cervical Adenocarcinoma and Cervical Squamous Cell Carcinoma
下载PDF
导出
摘要 目的:对比分析局部晚期宫颈腺癌与宫颈鳞癌对放化疗的反应,加强对宫颈腺癌治疗的认识。方法:收集2001年1月-2016年12月玉林市红十字会医院进行放化疗的68例局部晚期宫颈癌患者的临床资料,其中29例为宫颈腺癌患者,39例为宫颈鳞癌患者,对患者体重、年龄、组织学分级、FIGO分期、治疗方式和预后进行回顾性分析。结果:(1)与宫颈鳞癌患者相比,宫颈腺癌对放化疗效果欠佳(分别为5.1%和31.0%;P=0.0065),更多的宫颈腺癌患者需要手术补救治疗;(2)在随后的10年中位随访期间,宫颈腺癌患者表现出更短的总生存期(宫颈腺癌为7.4年,宫颈鳞癌为11年;P=0.01);(3)宫颈腺癌与宫颈鳞癌复发率(31.0%和28.2%)和间隔无瘤期(1.2年和2年),差异无统计学意义(P=0.79、0.11)。结论:局部晚期宫颈腺癌对放化疗的反应比宫颈鳞癌差,应针对其特点制定新的治疗策略。 Objective:To compare the reaction of local advanced cervical adenocarcinoma with cervical squamous cell carcinoma to radiotherapy and to strengthen the treatment of cervical adenocarcinoma.Method:From January 2001 to December 2016,in Red Cross Hospital of Yulin City,the clinical data of 68 patients with locally advanced cervical cancer for radiation and chemotherapy were collected,of which 29 cases of cervical adenocarcinoma patients,39 cases of cervical squamous carcinoma patients,the patient body weight,age,histological grade,FIGO stage,treatment and prognosis were retrospectively analyzed.Result:Compared with patients with cervical squamous cell carcinoma,the effect of chemotherapy was not good(5.1% and 31.0% respectively,P=0.0065),more patients with cervical adenocarcinoma require surgical remediation.In the following 10 years of follow-up,patients with cervical adenocarcinoma showed a shorter total survival(the cervical adenocarcinoma was 7.4 years and the cervical squamous cell carcinoma was 11 years,P=0.01).The differences between cervical adenocarcinoma and cervical squamous cell carcinoma(31.0% and 28.2%),and interval nodule(1.2 years and 2 years),no statistically significant difference(P=0.79,0.11).Conclusion:The effect of local advanced cervical adenocarcinoma on chemoradiotherapy is worse than that of cervical squamous cell carcinoma,and the new treatment strategy should be developed for its characteristics.
作者 庞贤芳
出处 《中外医学研究》 2017年第35期6-8,共3页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 宫颈腺癌 宫颈鳞癌 放化疗 Cervical adenocarcinoma Cervical squamous carcinoma Radiation and chemotherapy
  • 相关文献

参考文献3

二级参考文献79

  • 1BARNHOLTZ-SLOAN J,PATEL N,ROLLISON D,et al.Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity[J].Cancer Causes Control,2009,20:1129-1138.
  • 2KAMANGAR F,DORES G M,ANDERSON W F.Patterns of cancer incidence,mortality,and prevalence across five continents:defining priorities to reduce cancer disparities in different geographic regions of the world[J].J Clin Oncol,2006,24:2137-2150.
  • 3DUENAS-GONZALEZA C,ETINA-PEREZ L,ONATE-OCANA L F,et al.Multimodal treatment of locally advanced cervical cancer[J].Arch Med Res,2005,36(2):129-135.
  • 4GERSZTEN K,COLONELLO K,HERON D E,et al.Feasibility of concurrent cisplatin and extended field radiation therapy (EFRT) using intensity-modulated radiotherapy (IMRT) for carcinoma of the cervix[J].Gynecol Oncol,2006,102(2):182-188.
  • 5ROSE P G,BUNDY B N,WATKINGS E B,et al.Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer[J].N Engl J Med,1999,340:1144-1153.
  • 6GREEN J,KIRWAN J,TIERNEY J,et al.Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix[J].Coch-rane Database Syst Rev,2005,(3):CD002225.
  • 7RAO G G,ROGERS P,DRAKE R D,et al.Phase I clinical trial of weekly paclitaxel weekly carboplatin,and concurrent radiotherapy for primary cervical cancer[J].Gynecol Onco,l 2005,96(1):168-172.
  • 8FERLAY J, SOERJOMATARAM I, ERVIK M, et al. GLOBOCAN 2012 vl. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. ll [ M/OL ] . Lyon, France: International Agency for Research on Cancer [ 2014- 01-08 ] . http://globocan.ianc.fr.
  • 9PAPADIMITRIOU C A, SARRIS K, MOULOPOULOS L A, et al. Phase Ⅱ trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix [ J] . J Clin Oncol, 1999, 17(3):761-766.
  • 10FIORICA J, HOLLOWAY R, NDUBISI B, et al. Phase Ⅱ trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamons carcinomas of the cervix [ J ] . Gynecol Oncol, 2002, 85(1):89-94.

共引文献32

同被引文献9

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部